Acute treatment of ischemic stroke patients presenting more than eight-hours after symptom onset remains limited and largely unproven. Partial aortic occlusion using the NeuroFlo catheter can augment cerebral perfusion in animals. We investigated the safety and feasibility of employing this novel catheter to treat ischemic stroke patients eight-hours to 24 h following symptom onset
Background—The therapeutic time window for thrombolysis appears to be extremely short, probably beca...
BACKGROUND AND PURPOSE: Stroke remains the third most common cause of death in industrialized nation...
Acute ischemic stroke is a major cause of morbidity and mortality in Europe, North America, and Asia...
Acute treatment of ischemic stroke patients presenting more than eight-hours after symptom onset rem...
BACKGROUND: Acute treatment of ischemic stroke patients presenting more than eight-hours after sympt...
BACKGROUND AND PURPOSE: Fewer than 5% of patients with acute ischemic stroke are currently treated, ...
Ischaemic stroke is a leading cause of death and long-lasting disability. Several neuroprotective dr...
BACKGROUND: The time to initiate intravenous thrombolysis for acute ischemic stroke is generally lim...
Background and Purpose—Collateral flow augmentation using partial aortic occlusion may improve cereb...
BACKGROUND: The benefits of intravenous thrombolysis for acute ischemic stroke are still limited. OB...
Abstract : Acute ischemic stroke is a major cause of morbidity and mortality in industrialized natio...
BACKGROUND: We aimed to assess the safety and efficacy of thrombectomy for the treatment of stroke i...
BACKGROUND: The time to initiate intravenous thrombolysis for acute ischemic stroke is generally lim...
Ischaemic stroke is a leading cause of death and long-lasting disability. Several neuroprotective dr...
Stroke is currently the leading cause of long-term disability and the fifth leading cause of death i...
Background—The therapeutic time window for thrombolysis appears to be extremely short, probably beca...
BACKGROUND AND PURPOSE: Stroke remains the third most common cause of death in industrialized nation...
Acute ischemic stroke is a major cause of morbidity and mortality in Europe, North America, and Asia...
Acute treatment of ischemic stroke patients presenting more than eight-hours after symptom onset rem...
BACKGROUND: Acute treatment of ischemic stroke patients presenting more than eight-hours after sympt...
BACKGROUND AND PURPOSE: Fewer than 5% of patients with acute ischemic stroke are currently treated, ...
Ischaemic stroke is a leading cause of death and long-lasting disability. Several neuroprotective dr...
BACKGROUND: The time to initiate intravenous thrombolysis for acute ischemic stroke is generally lim...
Background and Purpose—Collateral flow augmentation using partial aortic occlusion may improve cereb...
BACKGROUND: The benefits of intravenous thrombolysis for acute ischemic stroke are still limited. OB...
Abstract : Acute ischemic stroke is a major cause of morbidity and mortality in industrialized natio...
BACKGROUND: We aimed to assess the safety and efficacy of thrombectomy for the treatment of stroke i...
BACKGROUND: The time to initiate intravenous thrombolysis for acute ischemic stroke is generally lim...
Ischaemic stroke is a leading cause of death and long-lasting disability. Several neuroprotective dr...
Stroke is currently the leading cause of long-term disability and the fifth leading cause of death i...
Background—The therapeutic time window for thrombolysis appears to be extremely short, probably beca...
BACKGROUND AND PURPOSE: Stroke remains the third most common cause of death in industrialized nation...
Acute ischemic stroke is a major cause of morbidity and mortality in Europe, North America, and Asia...